2018-2023 Global Antihypertensive Consumption Market Report

September 2018 | 139 pages | ID: 24A2A5951D7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Antihypertensive market for 2018-2023.

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.
Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.

Over the next five years, LPI(LP Information) projects that Antihypertensive will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Antihypertensive market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Diuretics 
• Angiotensin receptor blockers (ARBs) 
• Angiotensin converting enzyme (ACE) inhibitors 
• Beta blockers
• Alpha blockers
• Calcium channel blockers 
• Renin inhibitors
• Vasodilators 

Segmentation by application:

• Hosptial
• Clinic
• Home

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Pfizer
• Novartis
• Sanofi
• Merck
• Boehringer Ingelheim
• Lupin
• Johnson & Johnson
• Astra Zeneca
• Daiichi Sankyo
• Ranbaxy

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Antihypertensive consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Antihypertensive market by identifying its various subsegments.
• Focuses on the key global Antihypertensive manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Antihypertensive with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Antihypertensive submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antihypertensive Consumption 2013-2023
  2.1.2 Antihypertensive Consumption CAGR by Region
2.2 Antihypertensive Segment by Type
  2.2.1 Diuretics
  2.2.2 Angiotensin receptor blockers (ARBs)
  2.2.3 Angiotensin converting enzyme (ACE) inhibitors
  2.2.4 Beta blockers
  2.2.5 Alpha blockers
  2.2.6 Calcium channel blockers
  2.2.7 Renin inhibitors
  2.2.8 Vasodilators
2.3 Antihypertensive Consumption by Type
  2.3.1 Global Antihypertensive Consumption Market Share by Type (2013-2018)
  2.3.2 Global Antihypertensive Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Antihypertensive Sale Price by Type (2013-2018)
2.4 Antihypertensive Segment by Application
  2.4.1 Hosptial
  2.4.2 Clinic
  2.4.3 Home
2.5 Antihypertensive Consumption by Application
  2.5.1 Global Antihypertensive Consumption Market Share by Application (2013-2018)
  2.5.2 Global Antihypertensive Value and Market Share by Application (2013-2018)
  2.5.3 Global Antihypertensive Sale Price by Application (2013-2018)

3 GLOBAL ANTIHYPERTENSIVE BY PLAYERS

3.1 Global Antihypertensive Sales Market Share by Players
  3.1.1 Global Antihypertensive Sales by Players (2016-2018)
  3.1.2 Global Antihypertensive Sales Market Share by Players (2016-2018)
3.2 Global Antihypertensive Revenue Market Share by Players
  3.2.1 Global Antihypertensive Revenue by Players (2016-2018)
  3.2.2 Global Antihypertensive Revenue Market Share by Players (2016-2018)
3.3 Global Antihypertensive Sale Price by Players
3.4 Global Antihypertensive Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Antihypertensive Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Antihypertensive Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ANTIHYPERTENSIVE BY REGIONS

4.1 Antihypertensive by Regions
  4.1.1 Global Antihypertensive Consumption by Regions
  4.1.2 Global Antihypertensive Value by Regions
4.2 Americas Antihypertensive Consumption Growth
4.3 APAC Antihypertensive Consumption Growth
4.4 Europe Antihypertensive Consumption Growth
4.5 Middle East & Africa Antihypertensive Consumption Growth

5 AMERICAS

5.1 Americas Antihypertensive Consumption by Countries
  5.1.1 Americas Antihypertensive Consumption by Countries (2013-2018)
  5.1.2 Americas Antihypertensive Value by Countries (2013-2018)
5.2 Americas Antihypertensive Consumption by Type
5.3 Americas Antihypertensive Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Antihypertensive Consumption by Countries
  6.1.1 APAC Antihypertensive Consumption by Countries (2013-2018)
  6.1.2 APAC Antihypertensive Value by Countries (2013-2018)
6.2 APAC Antihypertensive Consumption by Type
6.3 APAC Antihypertensive Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Antihypertensive by Countries
  7.1.1 Europe Antihypertensive Consumption by Countries (2013-2018)
  7.1.2 Europe Antihypertensive Value by Countries (2013-2018)
7.2 Europe Antihypertensive Consumption by Type
7.3 Europe Antihypertensive Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antihypertensive by Countries
  8.1.1 Middle East & Africa Antihypertensive Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Antihypertensive Value by Countries (2013-2018)
8.2 Middle East & Africa Antihypertensive Consumption by Type
8.3 Middle East & Africa Antihypertensive Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Antihypertensive Distributors
10.3 Antihypertensive Customer

11 GLOBAL ANTIHYPERTENSIVE MARKET FORECAST

11.1 Global Antihypertensive Consumption Forecast (2018-2023)
11.2 Global Antihypertensive Forecast by Regions
  11.2.1 Global Antihypertensive Forecast by Regions (2018-2023)
  11.2.2 Global Antihypertensive Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Antihypertensive Forecast by Type
11.8 Global Antihypertensive Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Pfizer
  12.1.1 Company Details
  12.1.2 Antihypertensive Product Offered
  12.1.3 Pfizer Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Pfizer News
12.2 Novartis
  12.2.1 Company Details
  12.2.2 Antihypertensive Product Offered
  12.2.3 Novartis Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Novartis News
12.3 Sanofi
  12.3.1 Company Details
  12.3.2 Antihypertensive Product Offered
  12.3.3 Sanofi Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Sanofi News
12.4 Merck
  12.4.1 Company Details
  12.4.2 Antihypertensive Product Offered
  12.4.3 Merck Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Merck News
12.5 Boehringer Ingelheim
  12.5.1 Company Details
  12.5.2 Antihypertensive Product Offered
  12.5.3 Boehringer Ingelheim Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Boehringer Ingelheim News
12.6 Lupin
  12.6.1 Company Details
  12.6.2 Antihypertensive Product Offered
  12.6.3 Lupin Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Lupin News
12.7 Johnson & Johnson
  12.7.1 Company Details
  12.7.2 Antihypertensive Product Offered
  12.7.3 Johnson & Johnson Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Johnson & Johnson News
12.8 Astra Zeneca
  12.8.1 Company Details
  12.8.2 Antihypertensive Product Offered
  12.8.3 Astra Zeneca Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Astra Zeneca News
12.9 Daiichi Sankyo
  12.9.1 Company Details
  12.9.2 Antihypertensive Product Offered
  12.9.3 Daiichi Sankyo Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Daiichi Sankyo News
12.10 Ranbaxy
  12.10.1 Company Details
  12.10.2 Antihypertensive Product Offered
  12.10.3 Ranbaxy Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Ranbaxy News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antihypertensive
Table Product Specifications of Antihypertensive
Figure Antihypertensive Report Years Considered
Figure Market Research Methodology
Figure Global Antihypertensive Consumption Growth Rate 2013-2023 (K Units)
Figure Global Antihypertensive Value Growth Rate 2013-2023 ($ Millions)
Table Antihypertensive Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Diuretics
Table Major Players of Diuretics
Figure Product Picture of Angiotensin receptor blockers (ARBs)
Table Major Players of Angiotensin receptor blockers (ARBs)
Figure Product Picture of Angiotensin converting enzyme (ACE) inhibitors
Table Major Players of Angiotensin converting enzyme (ACE) inhibitors
Figure Product Picture of Beta blockers
Table Major Players of Beta blockers
Figure Product Picture of Alpha blockers
Table Major Players of Alpha blockers
Figure Product Picture of Calcium channel blockers
Table Major Players of Calcium channel blockers
Figure Product Picture of Renin inhibitors
Table Major Players of Renin inhibitors
Figure Product Picture of Vasodilators
Table Major Players of Vasodilators
Table Global Consumption Sales by Type (2013-2018)
Table Global Antihypertensive Consumption Market Share by Type (2013-2018)
Figure Global Antihypertensive Consumption Market Share by Type (2013-2018)
Table Global Antihypertensive Revenue by Type (2013-2018) ($ million)
Table Global Antihypertensive Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Antihypertensive Value Market Share by Type (2013-2018)
Table Global Antihypertensive Sale Price by Type (2013-2018)
Figure Antihypertensive Consumed in Hosptial
Figure Global Antihypertensive Market: Hosptial (2013-2018) (K Units)
Figure Global Antihypertensive Market: Hosptial (2013-2018) ($ Millions)
Figure Global Hosptial YoY Growth ($ Millions)
Figure Antihypertensive Consumed in Clinic
Figure Global Antihypertensive Market: Clinic (2013-2018) (K Units)
Figure Global Antihypertensive Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Antihypertensive Consumed in Home
Figure Global Antihypertensive Market: Home (2013-2018) (K Units)
Figure Global Antihypertensive Market: Home (2013-2018) ($ Millions)
Figure Global Home YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Antihypertensive Consumption Market Share by Application (2013-2018)
Figure Global Antihypertensive Consumption Market Share by Application (2013-2018)
Table Global Antihypertensive Value by Application (2013-2018)
Table Global Antihypertensive Value Market Share by Application (2013-2018)
Figure Global Antihypertensive Value Market Share by Application (2013-2018)
Table Global Antihypertensive Sale Price by Application (2013-2018)
Table Global Antihypertensive Sales by Players (2016-2018) (K Units)
Table Global Antihypertensive Sales Market Share by Players (2016-2018)
Figure Global Antihypertensive Sales Market Share by Players in 2016
Figure Global Antihypertensive Sales Market Share by Players in 2017
Table Global Antihypertensive Revenue by Players (2016-2018) ($ Millions)
Table Global Antihypertensive Revenue Market Share by Players (2016-2018)
Figure Global Antihypertensive Revenue Market Share by Players in 2016
Figure Global Antihypertensive Revenue Market Share by Players in 2017
Table Global Antihypertensive Sale Price by Players (2016-2018)
Figure Global Antihypertensive Sale Price by Players in 2017
Table Global Antihypertensive Manufacturing Base Distribution and Sales Area by Players
Table Players Antihypertensive Products Offered
Table Antihypertensive Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Antihypertensive Consumption by Regions 2013-2018 (K Units)
Table Global Antihypertensive Consumption Market Share by Regions 2013-2018
Figure Global Antihypertensive Consumption Market Share by Regions 2013-2018
Table Global Antihypertensive Value by Regions 2013-2018 ($ Millions)
Table Global Antihypertensive Value Market Share by Regions 2013-2018
Figure Global Antihypertensive Value Market Share by Regions 2013-2018
Figure Americas Antihypertensive Consumption 2013-2018 (K Units)
Figure Americas Antihypertensive Value 2013-2018 ($ Millions)
Figure APAC Antihypertensive Consumption 2013-2018 (K Units)
Figure APAC Antihypertensive Value 2013-2018 ($ Millions)
Figure Europe Antihypertensive Consumption 2013-2018 (K Units)
Figure Europe Antihypertensive Value 2013-2018 ($ Millions)
Figure Middle East & Africa Antihypertensive Consumption 2013-2018 (K Units)
Figure Middle East & Africa Antihypertensive Value 2013-2018 ($ Millions)
Table Americas Antihypertensive Consumption by Countries (2013-2018) (K Units)
Table Americas Antihypertensive Consumption Market Share by Countries (2013-2018)
Figure Americas Antihypertensive Consumption Market Share by Countries in 2017
Table Americas Antihypertensive Value by Countries (2013-2018) ($ Millions)
Table Americas Antihypertensive Value Market Share by Countries (2013-2018)
Figure Americas Antihypertensive Value Market Share by Countries in 2017
Table Americas Antihypertensive Consumption by Type (2013-2018) (K Units)
Table Americas Antihypertensive Consumption Market Share by Type (2013-2018)
Figure Americas Antihypertensive Consumption Market Share by Type in 2017
Table Americas Antihypertensive Consumption by Application (2013-2018) (K Units)
Table Americas Antihypertensive Consumption Market Share by Application (2013-2018)
Figure Americas Antihypertensive Consumption Market Share by Application in 2017
Figure United States Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure United States Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Canada Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Canada Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Mexico Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Mexico Antihypertensive Value Growth 2013-2018 ($ Millions)
Table APAC Antihypertensive Consumption by Countries (2013-2018) (K Units)
Table APAC Antihypertensive Consumption Market Share by Countries (2013-2018)
Figure APAC Antihypertensive Consumption Market Share by Countries in 2017
Table APAC Antihypertensive Value by Countries (2013-2018) ($ Millions)
Table APAC Antihypertensive Value Market Share by Countries (2013-2018)
Figure APAC Antihypertensive Value Market Share by Countries in 2017
Table APAC Antihypertensive Consumption by Type (2013-2018) (K Units)
Table APAC Antihypertensive Consumption Market Share by Type (2013-2018)
Figure APAC Antihypertensive Consumption Market Share by Type in 2017
Table APAC Antihypertensive Consumption by Application (2013-2018) (K Units)
Table APAC Antihypertensive Consumption Market Share by Application (2013-2018)
Figure APAC Antihypertensive Consumption Market Share by Application in 2017
Figure China Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure China Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Japan Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Japan Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Korea Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Korea Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure India Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure India Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Australia Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Australia Antihypertensive Value Growth 2013-2018 ($ Millions)
Table Europe Antihypertensive Consumption by Countries (2013-2018) (K Units)
Table Europe Antihypertensive Consumption Market Share by Countries (2013-2018)
Figure Europe Antihypertensive Consumption Market Share by Countries in 2017
Table Europe Antihypertensive Value by Countries (2013-2018) ($ Millions)
Table Europe Antihypertensive Value Market Share by Countries (2013-2018)
Figure Europe Antihypertensive Value Market Share by Countries in 2017
Table Europe Antihypertensive Consumption by Type (2013-2018) (K Units)
Table Europe Antihypertensive Consumption Market Share by Type (2013-2018)
Figure Europe Antihypertensive Consumption Market Share by Type in 2017
Table Europe Antihypertensive Consumption by Application (2013-2018) (K Units)
Table Europe Antihypertensive Consumption Market Share by Application (2013-2018)
Figure Europe Antihypertensive Consumption Market Share by Application in 2017
Figure Germany Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Germany Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure France Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure France Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure UK Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure UK Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Italy Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Italy Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Russia Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Russia Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Spain Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Spain Antihypertensive Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Antihypertensive Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Antihypertensive Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Antihypertensive Consumption Market Share by Countries in 2017
Table Middle East & Africa Antihypertensive Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Antihypertensive Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Antihypertensive Value Market Share by Countries in 2017
Table Middle East & Africa Antihypertensive Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Antihypertensive Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Antihypertensive Consumption Market Share by Type in 2017
Table Middle East & Africa Antihypertensive Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Antihypertensive Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Antihypertensive Consumption Market Share by Application in 2017
Figure Egypt Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Egypt Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure South Africa Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure South Africa Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Israel Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Israel Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure Turkey Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure Turkey Antihypertensive Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Antihypertensive Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Antihypertensive Value Growth 2013-2018 ($ Millions)
Table Antihypertensive Distributors List
Table Antihypertensive Customer List
Figure Global Antihypertensive Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Antihypertensive Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Antihypertensive Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Antihypertensive Consumption Market Forecast by Regions
Table Global Antihypertensive Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Antihypertensive Value Market Share Forecast by Regions
Figure Americas Antihypertensive Consumption 2018-2023 (K Units)
Figure Americas Antihypertensive Value 2018-2023 ($ Millions)
Figure APAC Antihypertensive Consumption 2018-2023 (K Units)
Figure APAC Antihypertensive Value 2018-2023 ($ Millions)
Figure Europe Antihypertensive Consumption 2018-2023 (K Units)
Figure Europe Antihypertensive Value 2018-2023 ($ Millions)
Figure Middle East & Africa Antihypertensive Consumption 2018-2023 (K Units)
Figure Middle East & Africa Antihypertensive Value 2018-2023 ($ Millions)
Figure United States Antihypertensive Consumption 2018-2023 (K Units)
Figure United States Antihypertensive Value 2018-2023 ($ Millions)
Figure Canada Antihypertensive Consumption 2018-2023 (K Units)
Figure Canada Antihypertensive Value 2018-2023 ($ Millions)
Figure Mexico Antihypertensive Consumption 2018-2023 (K Units)
Figure Mexico Antihypertensive Value 2018-2023 ($ Millions)
Figure Brazil Antihypertensive Consumption 2018-2023 (K Units)
Figure Brazil Antihypertensive Value 2018-2023 ($ Millions)
Figure China Antihypertensive Consumption 2018-2023 (K Units)
Figure China Antihypertensive Value 2018-2023 ($ Millions)
Figure Japan Antihypertensive Consumption 2018-2023 (K Units)
Figure Japan Antihypertensive Value 2018-2023 ($ Millions)
Figure Korea Antihypertensive Consumption 2018-2023 (K Units)
Figure Korea Antihypertensive Value 2018-2023 ($ Millions)
Figure Southeast Asia Antihypertensive Consumption 2018-2023 (K Units)
Figure Southeast Asia Antihypertensive Value 2018-2023 ($ Millions)
Figure India Antihypertensive Consumption 2018-2023 (K Units)
Figure India Antihypertensive Value 2018-2023 ($ Millions)
Figure Australia Antihypertensive Consumption 2018-2023 (K Units)
Figure Australia Antihypertensive Value 2018-2023 ($ Millions)
Figure Germany Antihypertensive Consumption 2018-2023 (K Units)
Figure Germany Antihypertensive Value 2018-2023 ($ Millions)
Figure France Antihypertensive Consumption 2018-2023 (K Units)
Figure France Antihypertensive Value 2018-2023 ($ Millions)
Figure UK Antihypertensive Consumption 2018-2023 (K Units)
Figure UK Antihypertensive Value 2018-2023 ($ Millions)
Figure Italy Antihypertensive Consumption 2018-2023 (K Units)
Figure Italy Antihypertensive Value 2018-2023 ($ Millions)
Figure Russia Antihypertensive Consumption 2018-2023 (K Units)
Figure Russia Antihypertensive Value 2018-2023 ($ Millions)
Figure Spain Antihypertensive Consumption 2018-2023 (K Units)
Figure Spain Antihypertensive Value 2018-2023 ($ Millions)
Figure Egypt Antihypertensive Consumption 2018-2023 (K Units)
Figure Egypt Antihypertensive Value 2018-2023 ($ Millions)
Figure South Africa Antihypertensive Consumption 2018-2023 (K Units)
Figure South Africa Antihypertensive Value 2018-2023 ($ Millions)
Figure Israel Antihypertensive Consumption 2018-2023 (K Units)
Figure Israel Antihypertensive Value 2018-2023 ($ Millions)
Figure Turkey Antihypertensive Consumption 2018-2023 (K Units)
Figure Turkey Antihypertensive Value 2018-2023 ($ Millions)
Figure GCC Countries Antihypertensive Consumption 2018-2023 (K Units)
Figure GCC Countries Antihypertensive Value 2018-2023 ($ Millions)
Table Global Antihypertensive Consumption Forecast by Type (2018-2023) (K Units)
Table Global Antihypertensive Consumption Market Share Forecast by Type (2018-2023)
Table Global Antihypertensive Value Forecast by Type (2018-2023) ($ Millions)
Table Global Antihypertensive Value Market Share Forecast by Type (2018-2023)
Table Global Antihypertensive Consumption Forecast by Application (2018-2023) (K Units)
Table Global Antihypertensive Consumption Market Share Forecast by Application (2018-2023)
Table Global Antihypertensive Value Forecast by Application (2018-2023) ($ Millions)
Table Global Antihypertensive Value Market Share Forecast by Application (2018-2023)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Antihypertensive Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Antihypertensive Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Antihypertensive Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Antihypertensive Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Antihypertensive Market Share (2016-2018)
Table Lupin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lupin Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lupin Antihypertensive Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Antihypertensive Market Share (2016-2018)
Table Astra Zeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astra Zeneca Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astra Zeneca Antihypertensive Market Share (2016-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Daiichi Sankyo Antihypertensive Market Share (2016-2018)
Table Ranbaxy Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ranbaxy Antihypertensive Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Ranbaxy Antihypertensive Market Share (2016-2018)